Wrinkle Treatment Face Serum for Men
30ml glass bottle
- Prevents and fights expression lines
- Stimulates the production of collagen
- Smoothes the skin with a slight tensor effect
- It has an emollient and moisturizing function
- Antioxidant and anti-aging effect
Men's anti-wrinkle face serum suitable for all male skin types in all seasons. Light and of immediate penetration, formulated for the daily treatment of the skin of the face and eye contour. The texture comes in the form of a transparent gel. Recommended for use in combination with the specific Men's Face Cream.
Designed for men, it helps to preserve the youthful appearance of the skin, making it visibly smoother. Visible effects from the first applications.
BUY NOW, FREE LOVVES SAMPLE SET WITH YOUR ORDER!
EXPRESS DELIVERY IN 2/4 WORKING DAYS
100% SECURE PAYMENT
We accept all the best payment systems
|- td >||All Credit Cards|
|- td >||PayPal|
|-||Payment in 3 installments without interest with Scalapay or Klarna|
|-||Cash on delivery (only Italy)|
A light serum with rapid absorption designed for the daily treatment of the skin of the face and eye contour. The functional active ingredients contained in the formulation act effectively on wrinkles by stimulating the natural production of collagen and promoting relaxation of the face muscles, which is useful for reducing expression lines.
Contains Panthenol (PANTHENOL) or the pro-vitamin of vitamin B5. The latter has a fundamental role in cell renewal, it also helps to carry out a moisturizing action on the skin.
It contains the unsaponifiable fraction of olive oil (OLEA EUROPAEA OIL UNSAPONIFIABLES), a principle rich in squalene, one of the most valuable substances present in nature, with an exceptional emollient function and great physiological compatibility with the sebum present in the stratum corneum.
Contains Peptides: proteins whose function is to imitate the physiological mechanisms of the skin. They perform an effective action of stimulating the natural production of collagen. They also promote a slight relaxation of the face muscles which is useful for reducing expression lines.
Peptide (Palmitoyl tripeptide-5): it is a patented peptide capable of stimulating the synthesis of collagen by fibroblasts.
Peptide (Palmitoyl hexapeptide-19): simulates the amino acid sequence of the C-terminal domain of SNAP-25, blocking its activity and thereby inhibiting the release of the neurotransmitter acetylcholine. The peptide is therefore useful in reducing expression lines caused by small contractions of the muscles of the face.
Hyaluronic acid (Sodium hyaluronate): is a physiological constituent of the connective tissue of the dermis. In addition to having a support and filling function, it also serves as a water reserve for the skin, retaining enormous quantities of water. For this function of "biological sponge" it absorbs shocks and supports the structure of the dermis, thanks also to the interactions with the collagen fibers, with the proteins of the matrix and other GAGs. The amount of hyaluronic acid in the skin decreases with age. This contributes to the formation of wrinkles, decreased elasticity, thinning and dry skin: all typical factors of aging.
The topical action of hyaluronic acid is achieved with the formation of a hydrated film, permeable to air and light, non-sticky, with a tightening effect. The skin thus gains elasticity and plasticity, is less sensitive to shocks and environmental aggressions and performs its protective functions better (reduction of water loss and barrier function).
Ingredients (INCI): AQUA, GLYCERIN, POTATO STARCH MODIFIED, PANTHENOL, SORBITOL, OLEA EUROPAEA OIL UNSAPONIFIABLES, COCO-CAPRYLATE, PALMITOYL TRIPEPTIDE-5, PALMITOYL HEXAPEPTIDE-19, SODIUM HYALURONATE, PARFUM, PHENETHYL ALCOHOL, CAPRYLYL GLYCOL, XANTHAN GUM, SODIUM PHYTATE, CITRONELLOL, LINALOOL, CITRAL, EUGENOL, ALPHA-ISOMETHYL IONONE, COUMARIN.
Product 100% free of: Parabens, SLS & SLES, PEG, Silicones, Paraffins, Alcohol, Dyes
The formulation and technical data of the product, as well as the safety assessment, have been notified to the Ministry of Health (P.I.F.) and the European portal (C.P.N.P.).